SCHEMBL6132071

SCHEMBL6132071

Cc1ccc(-c2[nH]ncc2-c2ccccc2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.49
RPS6KA3 P51812 4/20 0.49
TGFBR1 P36897 4/20 0.47
AKT1 P31749 2/20 0.46
KMT2A Q03164 2/20 0.46
AURKA O14965 1/20 0.46
CDK1 P06493 1/20 0.46
LYN P07948 1/20 0.46
PIM1 P11309 1/20 0.46
FGFR1 P11362 1/20 0.46
PRKACA P17612 1/20 0.46
RPS6KB1 P23443 1/20 0.46
CDK2 P24941 1/20 0.46
MARK3 P27448 1/20 0.46
GSK3B P49841 1/20 0.46
PRKCZ Q05513 1/20 0.46
PRKCD Q05655 1/20 0.46
ERBB4 Q15303 1/20 0.46
CDC42BPA Q5VT25 1/20 0.46
MARK2 Q7KZI7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132062 0.83 RPS6KA3 (0.70) RPS6KA3TGFBR1AKT1KMT2AAURKA
SCHEMBL3804222 0.75 CA12 (0.45) KMT2AALDH1A1LMNARAB9APOLB
SCHEMBL6132075 0.75 MAPK14 (0.71) RPS6KA3TGFBR1AKT1KMT2AAURKA
SCHEMBL6132091 0.74 RPS6KA3 (0.55) RPS6KA3TGFBR1AKT1KMT2AAURKA
SCHEMBL28327763 0.72 TP53 (0.42) TRPA1KMT2AHTR7ALDH1A1LMNA
SCHEMBL19577802 0.72 CA12 (0.47) KMT2AALDH1A1LMNARAB9APOLB
SCHEMBL1047559 0.71 CA12 (0.55) TRPA1KMT2AMAPK14HTR7ALDH1A1
SCHEMBL5248907 0.70 RPS6KA3 (0.81) RPS6KA3TGFBR1AKT1KMT2AAURKA
Bromide SCHEMBL11756541 0.69 RPS6KA3 (0.79) RPS6KA3TGFBR1AKT1KMT2AAURKA
SCHEMBL12369662 0.69 AKT1 (0.53) RPS6KA3TGFBR1AKT1KMT2AAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed